Adage Capital Partners Gp, L.L.C. Kempharm, Inc Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Kempharm, Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,650,000 shares of KMPH stock, worth $18 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,650,000
Previous 649,000
462.4%
Holding current value
$18 Million
Previous $3.21 Million
462.41%
% of portfolio
0.03%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding KMPH
# of Institutions
114Shares Held
30.2MCall Options Held
284KPut Options Held
24.1K-
Woodline Partners LP San Francisco, CA4.14MShares$20.4 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$14 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.34MShares$11.6 Million0.58% of portfolio
-
Altium Capital Management LP New York, NY1.85MShares$9.14 Million3.04% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...